TWO · 4161.TWO
Bioptik Technology Incorporation
NT$21.20+NT$0.20 (+0.95%)
Bioptik Technology Incorporation’s quoted price sits in the lower half of its reported 52-week range, 24.29% below the high.
Loading market information…
TWO · 4735.TWO · TWD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
AViTA Corporation’s quoted price sits in the upper half of its reported 52-week range, 11.89% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
AViTA Corporation’s forward annual dividend is NT$6.00 per share, paid quarterly. The forward yield is 16.69% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow AViTA Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
AViTA Corporation, established in 1996, is headquartered in New Taipei City, Taiwan. The company focuses on the creation and distribution of consumer medical devices for in-home use. Its extensive portfolio encompasses various personal healthcare gadgets, such as contact-free and infrared thermometers (designed for both ear and forehead), a selection of blood pressure monitors (available in arm, wrist, and innovative tubeless arm models), electronic lice removal combs, nasal aspirators, pulse oximeters, and nebulizers.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:52 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$21.20+NT$0.20 (+0.95%)
Bioptik Technology Incorporation’s quoted price sits in the lower half of its reported 52-week range, 24.29% below the high.
NT$13.80-NT$0.20 (-1.43%)
MegaPro Biomedical Co., Ltd’s quoted price sits in the upper half of its reported 52-week range, 19.06% below the high.
NT$30.60-NT$0.05 (-0.16%)
Level Biotechnology Inc.’s quoted price sits in the lower half of its reported 52-week range, 11.82% below the high.
NT$6.40-NT$0.31 (-4.62%)
Holy Stone Healthcare Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 36.32% below the high.
NT$24.00NT$0.00 (0.0%)
Wiltrom Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 20.66% below the high.
NT$36.20-NT$0.20 (-0.55%)
DV Biomed Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 40.46% below the high.
NT$11.80-NT$0.15 (-1.26%)
Cowealth Medical Holding Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 56.93% below the high.
NT$12.85-NT$0.55 (-4.1%)
Kim Forest Enterprise Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 44.01% below the high.
